title: Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?
authors.affiliation: Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
authors.forename: Hugo J A
authors.initials: HJ
authors.lastname: Adams
authors.affiliation: Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Kwee
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D019788:Fluorodeoxyglucose F18; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals; D012189:Retrospective Studies
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: International Harmonization Project; National Comprehensive Cancer Network International Prognostic Index; diffuse large B-cell lymphoma; fluorodeoxyglucose-positron emission tomography; response assessment